AFP and hepatocellular carcinoma: Besides, Huang C et al. examined serum N-glycan structures abundances in 1340 participants including AFP-negative HCC, chronic liver diseases, and healthy controls using N-glycan fingerprint technology, and 13N-glycan was selected as the most significant structure for distinguishing AFP-negative HCC and non-HCC patients by Lasso algorithm [70].